Gart-KO Mouse
一般名
Gart-KO
製品ID
S-KO-18164
背景情報
C57BL/6JCya
系統ID
KOCMP-14450-Gart-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Gart-KO Mouse(カタログ番号S-KO-18164)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Gart-KO
系統ID
KOCMP-14450-Gart-B6J-VA
遺伝子名
製品ID
S-KO-18164
遺伝子別名
Gaps, Prgs
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 16
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000023684
NCBIトランスクリプトID
NM_010256
ターゲット領域
Exon 3~4
有効領域の大きさ
~0.5 kb
遺伝子研究の概要
Gart, short for Glycinamide ribonucleotide transformylase, is a trifunctional polypeptide with phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, and phosphoribosylaminoimidazole synthetase activity. It is crucial for de novo purine biosynthesis and is highly conserved in vertebrates. Gart is involved in multiple signaling pathways, such as the Wnt/β -catenin pathway, and plays important roles in various biological processes including cell proliferation, migration, and energy homeostasis [1,2,3,4,5,6]. Genetic models, like gene knockout (KO) or conditional knockout (CKO) mouse models, can be valuable for studying Gart's functions in vivo.
In colorectal cancer, Gart has a novel methyltransferase function with its enzymatic activity center at the E948 site. It enhances the stability of RUVBL1 through methylating its K7 site, aberrantly activating the Wnt/β -catenin signaling pathway to promote tumor stemness. Pemetrexed, a GART -targeting compound, can suppress tumor growth [1]. In multiple myeloma, GART promotes cell proliferation and tumor stemness by activating the HSP90α/CDK6/β -catenin axis, and its inhibitor pemetrexed can suppress cell proliferation and tumor growth in a CDX model [4]. In non -small cell lung cancer, knockdown of GART inhibits cell proliferation and migration by inhibiting the activation of the PAICS -Akt -β -catenin pathway [6]. In colitis, inhibition of GART induces cellular apoptosis and suppresses the migration of intestinal epithelial cells through the MEKK3 -MKK3 -p38 MAPK pathway, affecting the p53 and PUMA regulation [5]. In breast cancer, inhibition of GART, a key enzyme in the purine de novo biosynthetic pathway, induces ERα degradation and prevents cell proliferation [7].
In conclusion, Gart is essential for de novo purine biosynthesis and is involved in multiple signaling pathways. Studies using KO/CKO mouse models (or other in vivo models inferred from the findings) have revealed its significant roles in various diseases, including colorectal cancer, multiple myeloma, non -small cell lung cancer, colitis, and breast cancer. Understanding Gart's functions provides potential therapeutic targets for these diseases.
References:
1. Tang, Chao, Ke, Mengying, Yu, Xichao, Gu, Chunyan, Yang, Ye. 2023. GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2301264. doi:10.1002/advs.202301264. https://pubmed.ncbi.nlm.nih.gov/37439412/
2. He, Lei, Wu, Binbin, Shi, Jian, Du, Juan, Zhao, Zhangwu. 2023. Regulation of feeding and energy homeostasis by clock-mediated Gart in Drosophila. In Cell reports, 42, 112912. doi:10.1016/j.celrep.2023.112912. https://pubmed.ncbi.nlm.nih.gov/37531254/
3. Zhang, Dongmei, Yue, Ying, Jiang, Shengyang, Tao, Tao, Gu, Xingxing. 2014. GART expression in rat spinal cord after injury and its role in inflammation. In Brain research, 1564, 41-51. doi:10.1016/j.brainres.2014.03.044. https://pubmed.ncbi.nlm.nih.gov/24709117/
4. Qian, Jinjun, Meng, Han, Wang, Ze, Yang, Ye, Gu, Chunyan. 2025. GART promotes multiple myeloma malignancy via tumor stemness mediated by activating the HSP90α/CDK6/β-catenin axis. In European journal of pharmacology, 996, 177584. doi:10.1016/j.ejphar.2025.177584. https://pubmed.ncbi.nlm.nih.gov/40185325/
5. Bai, Jian-An, Jie, Hua, Wei, Sun, Guo, Huarui, Tang, Qiyun. . GART mediates the renewal of intestinal epithelial barrier via p38/p53/PUMA cascade in colitis. In Apoptosis : an international journal on programmed cell death, 21, 1386-1397. doi:. https://pubmed.ncbi.nlm.nih.gov/27718035/
6. Chen, Zhuo, Ding, Yu-Heng, Zhao, Mei-Qi, Qian, Xiang, Ji, Xu-Ming. 2025. GART promotes the proliferation and migration of human non-small cell lung cancer cell lines A549 and H1299 by targeting PAICS-Akt-β-catenin pathway. In Frontiers in oncology, 15, 1543463. doi:10.3389/fonc.2025.1543463. https://pubmed.ncbi.nlm.nih.gov/40201340/
7. Cipolletti, Manuela, Leone, Stefano, Bartoloni, Stefania, Acconcia, Filippo. 2023. A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma. In Frontiers in endocrinology, 14, 1129162. doi:10.3389/fendo.2023.1129162. https://pubmed.ncbi.nlm.nih.gov/37143728/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
